Arsenic is an environmental contaminant that induces congenital malformations, primarily neural tube defects, in laboratory animals, and it may contribute to human birth defects. The acute doses of arsenicals required to elicit teratogenesis in outbred strains of mice, however, are orders of magnitude higher than those to which humans are exposed environmentally. In order to examine interactions between arsenite administration during neurulation and murine genotype, the present study compares two inbred mouse strains, establishes a teratogenic dose of arsenite, and evaluates the effect of the splotch mutation on arsenic-induced teratogenesis. SWV/Fnn or C57BL/6J females were injected intraperitoneally with sodium arsenite (10 mg/kg) on days 6.5, 7.0, 7.5, 8.0, 8.5, or 9.0 of gestation. A dose-response study was carried out in the C57BL/6J strain, and the effect of the splotch mutation, introduced via the male (C57BL/6J Sp/؉), was assessed. Fetuses were examined for external, visceral, and skeletal malformations. Fetuses from crosses of C57BL/6J females with C57BL/6J Sp/؉ males were genotyped by PCR. Ten-mg/kg sodium arsenite was teratogenic in nearly 50% of C57BL/6J fetuses, and the C57BL/6J strain was significantly more sensitive to arsenite-induced embryolethality and teratogenicity than the SWV/Fnn strain. The spectrum of malformations produced was dependent on the gestational time point of arsenite administration. Introduction of the splotch allele significantly increased neural tube defects and other specific malformations. This result demonstrates that a mutation in a single gene can increase sensitivity to arsenic-induced birth defects. This murine study examines the interaction between arsenite-induced teratogenicity and genotype.
The metalloid, arsenic, is a common environmental contaminant, occurring in both organic complexes and inorganic forms. Inorganic arsenic is more acutely toxic and is the predominant form identified in drinking water (National Research Council, 1994) where conditions favor oxidation of trivalent to pentavalent arsenic (Del Razo, 1990) . Trivalent arsenic (arsenite) is substantially more toxic than the pentavalent form (arsenate), and a significant portion of the toxicity of arsenate is thought to be secondary to its in vivo reduction to arsenite (Winski and Carter, 1995) . In addition to the wellestablished acute toxicity of arsenic, chronic exposure to this element in drinking water has been causally associated in humans with skin, lung, and bladder cancers (Chen et al., 1998) , as well as with peripheral vascular defects (Wu et al., 1989 ; International Agency for Research on Cancer, 1987) , peripheral neuropathy, anemia, hepatomegaly, pigmentation abnormalities, and numerous other health effects (Rossman, 1998) .
Beyond its effects on adult organisms, arsenic is a wellestablished teratogen in chickens (Ridgeway and Karnofsky, 1952) and rodents (Beaudoin, 1974; Carpenter, 1987; Ferm et al., 1971; Hood and Bishop, 1972; Morrissey and Mottet, 1983; Willhite, 1981) . When administered to pregnant rodents intravenously (Ferm and Carpenter, 1968) or intraperitoneally (Beaudoin, 1974; Hood and Bishop, 1972; Hood and Harrison, 1982) , arsenic produces embryo and fetal lethality. At lower doses, it causes a variety of malformations, particularly cephalic axial dysraphic disorders (encephalocele and exencephaly), but also including anophthalmia and genitourinary and skeletal defects. Oral administration results in the same spectrum of lethality and malformations, but adverse effects are seen less frequently, and the doses required are considerably higher (Baxley et al., 1981; Hood and Harrison, 1982; Hood et al., 1978) . Regardless of the route of arsenic administration, teratogenicity occurs in a dose-dependent fashion, and the types of malformations observed depend primarily on the gestational timing at which arsenic is administered (Willhite and Ferm, 1984) . As with acute toxicity of arsenic, the valence form of this element determines teratogenic potency. In mice, arsenite is about 3 times more potent than arsenate when either is administered ip. The trivalent form produces teratogenic effects at an elemental-arsenic-equivalent dose of 5.8 -6.9 mg/kg (10 -12 mg/kg sodium arsenite, Hood, 1972) versus 18.1 mg/kg for the pentavalent form (45 mg/kg sodium arsenate, Hood and Bishop, 1972) . In a whole embryo culture system, arsenite was found to have approximately 6 times the teratogenic potency of arsenate when doses are adjusted to elemental-arsenic equivalents (Chaineau et al., 1990) .
Despite the strength of evidence that arsenic is a mammalian teratogen, it is not known whether this environmental pollutant is teratogenic to humans. Species differences are commonly observed in teratogenesis, but the case of arsenic is further complicated by the fact that doses of this metalloid required to elicit neural tube and other defects, as well as embryolethality in laboratory animals, are orders of magnitude higher than those associated with human environmental exposures (DeSesso et al., 1998; Golub et al., 1998) . Nonetheless, humans are likely to differ from laboratory rodents in their sensitivity to teratogens, particularly when, in the case of humans, exposure to a teratogen is combined with environmental exposure to other chemicals (Wilson, 1973) . Epidemiologic studies have found associations between elevated arsenic levels in drinking water and stillbirths (Borzsonyi et al., 1992) , as well as spontaneous abortions (Aschengrau et al., 1989; Borzsonyi et al., 1992) . Moreover, it is likely that different human populations will vary in their sensitivities. The carcinogenic effects of arsenic, for example, have been shown to vary widely among different populations exposed to similar levels of arsenic, leading to the hypothesis that genetic polymorphisms may account for the differences in cancer levels (Kaiser, 1998) . Although differential sensitivities of mouse strains to other metal teratogens have been demonstrated (Gale and Layton, 1978; Layton and Layton, 1979) , no report of differential strain sensitivity to arsenic-induced teratogenesis has been published (Shalat et al., 1996) . The present study tests the teratogenic interaction between genetic background and arsenic exposure by comparing arsenic-induced teratogenicity during the period of neurulation in two inbred strains of mice, C57BL/6J and Swiss Vancouver (SWV/Fnn).
Teratogenic interactions between genotype and arsenic exposure were further investigated by narrowing the focus to a single gene. Since the teratogenic profile of arsenic in mice includes predominantly neural tube defects (Wlodarczyk et al., 1996) , we considered the possibility that a mutation in a gene involved in a variety of neural tube developmental processes, including neural tube closure, may confer added sensitivity to this teratogenic effect. Pax3 is one of a family of paired-box genes initially described in Drosophila and conserved in many vertebrate species. Pax genes encode transcription factors expressed primarily during development, and 4 of the 9 murine Pax genes have been associated with classical mouse mutants (Wehr and Gruss, 1996) . Splotch (Sp) (Russell, 1947 ) is a semi-dominant Pax3 mouse mutant (Epstein et al., 1993) that demonstrates neural tube defects in homozygotes (Sp/Sp), which die between days 13 and 14 of gestation (Auerbach, 1954) . The penetrance of neural tube defects in Sp/Sp mice is highly variable, depending on genetic background (Harris and Juriloff, 1997; Moase and Trasler, 1992) . C57BL/6J Sp/Sp mice reportedly exhibit 100% spina bifida aperta and 56% exencephaly (Auerbach, 1954) , while outcrossing, in one report, resulted in only 25% spina bifida aperta but 100% exencephaly in Sp/Sp progeny (Moase and Trasler, 1987) . Splotch heterozygotes (Sp/ϩ) demonstrate defective neural-crest-cell migration, which is manifested as a white spot on the belly and sometimes white paws, as well as an increased incidence of neural tube defects compared to the background C57BL/6J genotype (Auerbach, 1954; Estibeiro et al., 1993; Konyukhov and Mironova, 1979) . The splotch mutation of the murine Pax3 consists of a 5-base-pair change at the 3Ј extremity of intron 3. The mutated sequence results in aberrantly spliced mRNA and ultimately leads to nonfunctional Pax3 polypeptides (Epstein et al., 1993) . Expressed primarily during embryogenesis, Pax3 is a transcription factor that contains both a paired-box and a homeobox DNA-binding domain (Gruss and Walther, 1992) . Pax3 is expressed in the dorsal aspect of the developing neural tube, in neural crest cells, and in developing limb buds. It has also been implicated in neural tube closure (Goulding et al., 1993) and in regulation of muscle development (Daston et al., 1996; Maroto et al., 1997; Tajbakhsh et al., 1997) . Mutations in PAX3, the human homologue of murine Pax3, have been associated with the autosomal dominant Waardenburg syndrome type 1 (Foy et al., 1990) and type 3 (Hoth et al., 1993) in humans. Waardenburg syndrome, which exhibits a number of similarities to the murine phenotype, splotch, includes a wide range of developmental abnormalities affecting such diverse characteristics as hearing, pigmentation, and cardiac and skeletal morphology (DiGeorge et al., 1960; Waardenburg, 1951) . Homozygotes for the mutations that cause Waardenburg syndrome types 1 and 3 are believed to have a higher prevalence of neural tube defects (Read and Newton, 1997) . In the present study, C57BL/6J females were mated with C57BL/6J Sp/ϩ males in order to introduce the splotch allele, theoretically, into one-half of the resulting fetuses. It could then be observed whether malformations produced by arsenic treatment, particularly neural tube defects, increased. Individual fetuses were genotyped for the presence of the splotch allele in order to compare the incidence of neural tube defects in wildtype (ϩ/ϩ) fetuses with their Sp/ϩ littermates.
MATERIALS AND METHODS
C57BL/6J mice, purchased from Jackson Laboratories (Bar Harbor, ME) or bred in our animal facility, were maintained in a climate-controlled room under a 12-h alternating light/dark cycle (900 -2100 h light) and supplied with food (Purina Formulab 5008) and tap water ad libitum. C57BL/6J mice with the splotch mutation, originally from Jackson Laboratories, were bred in our animal facility, as were Swiss Vancouver (SWV/Fnn) mice. The SWV/Fnn colony was established from mice kindly provided by Dr. Richard Finnell (Texas A&M University, College Station, TX). All strains of mice were maintained on the above regimen and were housed and treated in accordance with institutional policy. The breeding procedure consisted of placing single males with 1 to 5 virgin females two h before the end of the dark cycle (0700 h). At the end of 3 h (1000 h), males were removed and females were checked for the presence of a vaginal plug, indicating copulation had taken place (designated gestational day 0). On gestational day 6.5, 7.0, 7.5, 8.0, 8.5, or 9 .0, pregnant females were injected intraperitoneally with 10 mg/kg sodium arsenite (Fisher Scientific, Pittsburgh, PA) dissolved in deionized water. The arsenite solution was prepared immediately prior to injection, at a strength of 1 mg/ml, and was injected in a volume of 10 l/g mouse weight. The C57BL/6J females that were mated with males carrying the splotch mutation, as well as those treated with alternative doses (5, 15, or 20 mg/kg) of sodium arsenite, were injected exclusively on day 8.0. Morning injections (days 7.0, 8.0, and 9.0) were carried out between 800 and 1000 hours, and evening injections (days 6.5, 7.5, and 8.5) were performed between 2000 and 2200 hours. On day 18 of gestation, females were sacrificed by cervical dislocation under ether anesthesia. Fetuses were dissected from the uterus, examined for sex determination, and observed for external morphological defects. Half the fetuses from each litter were preserved in Bouin's solution and analyzed for visceral malformations using Wilson's sectioning technique (Wilson, 1965) . The other half were doublestained with alizarin red and alcian blue using the techniques of Inouye (1976) and Kimmel and Trammell (1981) as modified by Kuczuk and Scott (1984) and examined for skeletal anomalies. All malformations were named according to the standardized nomenclature of Wise et al. (1997) .
For mating between splotch and C57BL/6J animals, gestational day 18 visceral yolk sacs were collected for the purpose of genotyping individual fetuses. Genomic DNA was extracted from the visceral yolk sacs by the method of Thomas et al. (1989) as modified by Couse et al. (1994) and genotyped for the wild-type and splotch alleles of Pax3 by a PCR technique. In order to distinguish splotch heterozygote (Sp/ϩ) fetuses from their wildtype (ϩ/ϩ) litter mates, visceral yolk sac DNA (500 ng) was denatured (94°C for 15 min) in the presence of oligonucleotide primers (500 ng each) designed to bind specific sequences within the wild-type or mutant Pax3 gene: 5Ј-GAG AGG GTT GAG TAC GTT AGC-3Ј (forward, intron 3); 5Ј-CGG CTG ATA GAA CTC ACT GGA-3Ј (reverse, exon 4, wild-type); and 5Ј-CGG CTG ATA GAA CTC ACA CAC-3Ј (reverse, exon 4, splotch, Tajbakhsh et al., 1997) . The 10 l reaction, consisting of buffer [50 mM KCl, 10 mM Tris (pH 8.3), 3 mM MgCl 2 , 0.125 mg/ml BSA], genomic DNA, primers, dNTPs (0.2 mM), and Taq polymerase, was subjected to PCR for 50 cycles: 94°C for 45 s, 60°C for 1 min, and 72°C for 1 min. The resultant PCR product was 110 base pairs in length and could be readily observed on a 1.6% agarose gel stained with ethidium bromide (0.005%). PCR reactions for the wild-type and mutant alleles were carried out separately for each fetus, and the presence of a product in the reaction using splotch primers was considered diagnostic of the heterozygote genotype.
Resorption rates and fetal weight data from all litters were statistically analyzed by 2-tailed t-test (p Յ 0.05) for differences between controls and arsenite-treated litters at all gestational time points selected (days 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0) . Malformation rates resulting from arsenite treatment were analyzed for differences with controls as well as for differences between the C57BL/6J and SWV/Fnn strains. Due to a significant litter effect and consequent lack of independence of the fetal malformation and weight data, the litter was used as the statistical unit for comparison. For each litter, the percentage of affected fetuses was determined, after which the percentages were averaged for all litters treated at the same gestational time point. Mean litter percentages were thereby established, and proportions for all litters were compared by t-test for significance (p Յ 0.05). Since arsenic is a known teratogen, a 1-tailed t-test was used for comparison to controls for each strain. For all other comparisons, a 2-tailed t-test was employed. Groups treated with arsenite on different gestational days were considered independent. Thus, comparisons of each group with controls were not adjusted using the Bonferroni procedure, while multiple comparisons of malformation data between groups were appropriately adjusted. The 2-tailed t-test with the Bonferroni adjustment was also used to determine the statistical significance of differences between litters in which the C57BL/6J female was mated with a wild-type (ϩ/ϩ) male versus with a splotch heterozygote (Sp/ϩ) male, and was administered arsenite on gestational day 8.0. For the malformation data correlated with fetal genotype or sex, there would have been too few fetuses per group to compare mean litter percentages of each malformation by genotype. Thus, the percentages of total fetuses are presented, and comparisons were made using the chi-square statistic for significance (p Յ 0.05).
RESULTS
Data from range-finding studies, intended to establish a teratogenic dose of arsenite in C57BL/6J mice, are presented in Table 1 . A single, intraperitoneal injection of 20 mg/kg sodium arsenite in water was lethal to all dams treated. The mice became noticeably lethargic within a few min following arsenite administration and demonstrated increasing lethargy until death, 48 -72 h post-injection. The 15-mg/kg dose was not maternally lethal, and the dams displayed no overt signs of arsenic intoxication. This dose was, however, 100% embryolethal. The 10-mg/kg dose was teratogenic in nearly half the fetuses, following treatment at gestational day 8.0, as well as approximately tripling the resorption rate observed in watertreated controls. Finally, the 5-mg/kg dose resulted in no differences compared with controls, except that the fetuses exhibited significantly increased weight at day 18. The defects noted at this dose (Table 1) consisted entirely of small regions of ossification lateral to the seventh cervical vertebra which were scored as cervical ribs. There was also a single observation of polydactyly of the left hindlimb (duplication of digit 1).
The reproductive effects of a single, intraperitoneal injection of sodium arsenite (10 mg/kg) on different days of gestation in C57BL/6J and SWV/Fnn mice are summarized in Table 2 . Compared with vehicle-treated (gestational day 8.0) controls, arsenite administration at this dose produced increased fetal mortality, as indicated by resorption percentage, at all treatment days in C57BL/6J mice, except gestational day 7.0. In contrast, the SWV/Fnn strain demonstrated no statistically significant increase in resorptions at any of the treatment days. In the C57BL/6J strain, there seems to be a general trend toward increased resorption rates following arsenite treatment at the later gestational times ( Table 2 ). The trend is not observed in the SWV/Fnn strain at this dose, but in the C57BL/6J strain, it extends to later gestational times than those reported in this study. Specifically, intraperitoneal injection of arsenite (10 mg/kg) on gestational day 12.0 (4 litters, 35 implantations) resulted in a 77.1% resorption rate. The same dose of arsenite administered on day 13.0 (5 litters, 41 implantations) induced a resorption rate of 87.8%. Arsenite administration at several of the earlier gestational time points resulted in decreased fetal weights in both strains.
A comparison of fetal exencephaly, induced by arsenite administration at different gestational time points in C57BL/6J and SWV/Fnn mice, is also presented in Table 2 . A proportion of fetuses demonstrated exencephaly when maternal injection of arsenite was performed on gestational day 7.0, 7.5, 8.0, or 8.5 in the C57BL/6J strain and day 7.5, 8.0, or 8.5 in the SWV/Fnn strain. As with fetal mortality, the C57BL/6J strain proved significantly more sensitive to the induction of exencephaly by arsenite.
Maternal administration of sodium arsenite resulted in a variety of fetal malformations and variations other than exencephaly, depending on the day of gestation. Table 3 summarizes the mean litter percentages for the more common malformations and variations. Anophthalmia and microphthalmia were seen almost exclusively in the C57BL/6J strain. Although the dark pigmentation of the eye in the C57BL/6J mouse permits external observation of eye defects, the same is not true for the SWV/Fnn mouse. Thus, only eye malformations that could be confirmed by sectioning through the eye were included in the strain comparison. Peak sensitivity in the C57BL/6J strain occurred at gestational day 7.0. A single anophthalmia was noted in an SWV/Fnn fetus treated on day 9.0. Relatively low percentages of omphalocele were also noted in the C57BL/6J strain at several gestational time points, but again, only a single example of this malformation was observed in the SWV/Fnn strain-that resulting from treatment at day 7.0 (Table 3) .
Hydrocephaly, presenting as dilated intracerebral ventricles and/or external hydrocephaly (Wise et al., 1997) , was the most common visceral malformation produced by maternal arsenite administration in C57BL/6J mice, and this defect was observed at every gestational time point in this study. The extent of dilation required for a fetus to be labeled hydrocephalic is subjective. In this study, the criteria for defining hydrocephaly was conservative, as indicated by the 0% prevalence of this malformation in the C57BL/6J mice, which contrasts with 1-3% spontaneous rate previously reported in this strain (Dagg, 1966) . Enlarged bladder was the only malformation seen exclusively in the C57BL/6J strain ( Table 3) . The C57BL/6J strain was significantly more sensitive than the SWV/Fnn strain to the induction of cardiovascular defects by arsenite on day 7.0 of gestation (Table 3 ). The most common cardiovascular malformations were right-sided aortic arch and/or pulmonary trunk, which together comprised 80% of cardiovascular malformations in the C57BL/6J strain. However, transposition of the great vessels, enlarged ventricular or atrial chambers, ventricular septal defects, aortic stenosis, ectopic subclavian vessel, persistent truncus arteriosus, dilated aorta, malpositioned heart (levocardia), and an aorticopulmonary septal defect were also observed. Infrequently occurring (Ͻ5% of fetuses) external and visceral defects not delineated in Tables 2 and 3 included diaphragmatic hernia, agnathia, micrognathia, cleft palate, facial cleft, aglossia, single naris, naris atresia, hypoplastic nose, low-set ears, gastromegaly, mottled kidney, double kidney, ectopic testis, right forelimb ectrodactyly (digit 5), tail agenesis, and a single observation of spina bifida aperta (arsenite treatment at day 6.5). These malformations occurred primarily in the C57BL/6J strain. With the exception of two observations of right forelimb ectrodactyly (digit 5), the skeletal malformations seen in this study were limited to the axial skeleton, including the ribs. Mean litter percentages of these defects are delineated in Table  3 . Malformations classified as fusions included fusions of the vertebral arches, bodies, or centra. Misshapen vertebral arches or centra were classified as malformed vertebrae, while rib malformations included bifurcated, rudimentary, or detached ribs, as well as absent ribs. Supernumerary ribs, presenting as cervical or lumbar ribs, were classified separately (Table 3) . Both C57BL/6J and SWV/Fnn mice exhibited all of these skeletal defects, but, as was the case for previous malformations and variations, the former strain was generally more sensitive. An exception to this is noted for rib malformations and cervical ribs, for which SWV/Fnn mice demonstrated equal or higher peak sensitivities, although C57BL/6J mice exhibited a longer period of sensitive gestational days.
Mating wild-type (ϩ/ϩ) C57BL/6J females with C57BL/6J males heterozygous for the splotch mutation (Sp/ϩ), then injecting the females with arsenite on gestational day 8.0, resulted in exacerbation of several of the malformations produced by arsenite in the C57BL/6J strain (Table 4) . For example, introduction of the splotch allele via the male significantly increased the mean litter percentage of exencephaly from 15.7% to 29.6%, and spina bifida aperta resulting from arsenite administration was also observed in these fetuses. Of the axial skeletal malformations and variations, only vertebral fusions and cervical ribs increased significantly (Table 4) . Most of the fetuses that were scored for skeletal malformations exhibited widened vertebral arches in the lumbar region, although this observation was not quantified, nor was widening of vertebral arches scored as a defect.
In order to confirm that the increased malformations, noted in Table 4 , were attributable to the presence of the splotch allele, 148 fetuses from 22 litters were genotyped. Of these, 68 (45.9%) were wild-type and 80 (54.1%) were heterozygous for the splotch allele (Table 5) . Wild-type fetuses demonstrated 11.8% exencephaly, whereas 46.3% of the heterozygotes exhibited this malformation. All fetuses with spina bifida aperta proved to be heterozygous for the splotch allele. Likewise, the increase in omphalocele seemed directly attributable to the presence of the splotch allele, although this defect was not sufficiently common to demonstrate statistical significance. Other fetal malformations increased by the introduction of the splotch allele (Table 4) failed to show a significant association with the presence of that allele in individual fetuses ( Table 5 ). The open neural tube defects, exencephaly and spina bifida aperta, observed in this study were distributed unequally between the sexes. Table 6 presents a distribution by sex of these malformations in SWV/Fnn, C57BL/6J (ϩ/ϩϫϩ/ϩ), and C57BL/6J (ϩ/ϩ ϫ Sp/ϩ) mice. In all three of these groups, female fetuses were approximately twice as likely to have exencephaly. Conversely, more males exhibited spina bifida aperta, although the uneven distribution of this malformation could not be confirmed statistically because the defect was relatively infrequent.
DISCUSSION
The types of arsenite-induced malformations noted in the present study are essentially in agreement with those reported by Hood (1972) . The C57BL/6J strain, however, is considerably more susceptible to the full spectrum of defects produced by arsenite administration than is the outbred strain of mouse used in the cited investigation. Although arsenate, the more environmentally prevalent inorganic arsenical, is also teratogenic (Beaudoin, 1974; Chaineau et al., 1990; Hood and Bishop, 1972) , this pentavalent form is reduced in vivo to the trivalent form, arsenite, prior to metabolism by methylation. Thus, arsenite, the more potent teratogen, was used in this investigation in order to minimize potential strain differences in the transport and reduction of arsenate. The gestational time c A single spina bifida aperta was observed in a female fetus from a dam treated on day 6.5.
d All litters were treated on day 8.0; data include 10 litters not genotyped for this study.
e X 2 indicates a significant sex difference (p Յ.05).
points chosen for this study (days 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0) were selected to encompass the period of neurulation in the mouse. Likewise, the single gestational time point (day 8.0), chosen for the assessment of the effect of the splotch mutation on arsenite-induced teratogenesis, is one of the time points of greatest sensitivity to exencephaly in the C57BL/6J strain. Several investigators have reported differential sensitivity of C57BL/6 and SWV mice to the induction of neural tube defects by a variety of teratogenic agents and treatments. These include valproic acid in vivo (Finnell et al., 1988; Finnell and Chernoff, 1985) and in vitro (Naruse et al., 1988) , 4-propyl-4-pentenoic acid (Finnell et al., 1988) , hyperthermia (Finnell et al., 1986) , and the enantiomers of sodium 2-ethylhexanoate (Collins et al., 1992) . Although in some cases the teratogen of interest in these studies was administered at only a single gestational time point, these reports, without exception, found the SWV strain to be more sensitive to the induction of exencephaly than the C57BL/6 strain. It has been suggested that differential sensitivity of inbred strains of mice to the teratogenic induction of specific malformations reflects genetic susceptibility to that particular malformation (Finnell et al., 1988) . Thus, the SWV genotype has been proposed to manifest itself in a neural tube closure process that is exceptionally sensitive to disruption, particularly by teratogens that share specific mechanisms (Juriloff et al., 1991) .
In the present study, SWV/Fnn proved to be the resistant strain, demonstrating reduced mean litter percentages of exencephaly, compared to the C57BL/6J strain, at all time points of arsenite administration that resulted in this defect. This observation is in contrast to the strain sensitivity reported for all other published teratogens. However, it is in accordance with the finding in our laboratory that C57BL/6 mice are more sensitive than SWV/Fnn to the production of exencephaly by cadmium (Hovland et al., 1999) . This bi-directional sensitivity to the induction of exencephaly by various teratogenic agents and treatments would seem to indicate that strain sensitivity is mechanism-dependent, not merely a reflection of spontaneous malformation rates. Kalter (1965) espoused this same argument with regard to cleft palate, noting that the relative sensitivity of various strains of mouse to this malformation differed, depending on the teratogenic agent. Ultimately, the variations in genotype that prove responsible for differential strain sensitivity to teratogenesis may provide clues to the various mechanisms by which different teratogens produce morphologically similar malformations.
Introduction of the splotch allele via mating of C57BL/6J females with C57BL/6J Sp/ϩ males increased the mean litter percentage of arsenite-induced exencephaly when compared to wild-type litters treated with arsenite on the same gestational day. Additionally, spina bifida aperta secondary to arsenite administration at gestational day 8.0 was observed in these splotch litters but not in the background strain without this mutation. The percentage of wild-type fetuses resulting from the mating of C57BL/6J females with C57BL/6J Sp/ϩ males and exhibiting arsenite-induced exencephaly, when compared to the percentage resulting from arsenite treatment (gestational day 8.0) of C57BL/6J dams mated with C57BL/6J males, was found not to be significantly different. Heterozygous fetuses, however, exhibited a significantly higher rate of exencephaly. Thus, correlation of the exencephaly phenotype to fetal genotype demonstrated that the splotch allele accounts for the increase in this malformation. All fetuses with spina bifida aperta genotyped in this phase of the investigation proved to be heterozygous for the splotch allele. The morphological variants, curly tail and kinked tail, which often accompany spina bifida aperta, were observed in six fetuses without spina bifida aperta. All of these fetuses were also heterozygous for the splotch allele. It is believed that splotch is the only current animal model for arsenic-induced spina bifida aperta. Taken together, the exencephaly and spina bifida aperta results demonstrate that a mutation in a single gene can confer added sensitivity to neural tube defects produced by an environmental teratogen.
Neural tube defects are often distributed unevenly between the sexes. For example, human fetuses presenting with anencephaly are more frequently female than male (Elwood and Elwood, 1980) , and a study of hyperthermia-induced exencephaly in mice found female fetuses to be more sensitive (Webster and Edwards, 1984) . Furthermore, genetically induced exencephaly, whether by gene inactivation or development of a strain with a high rate of spontaneous exencephaly, is more frequent in female fetuses when one sex predominates (Copp et al., 1990; Harris and Juriloff, 1997) . Although the foregoing illustrates the generally greater sensitivity of female fetuses to exencephaly, the level of disparity (approximately 2:1) noted in the present study seems somewhat rare in animal models. In light of a report of a similar female to male ratio observed in Macs knockout mice (Stumpo et al., 1995) , this observation may provide a rationale to look into the effect of arsenite on Macs, which codes for myristoylated, alanine-rich C-kinase substrate (MARCKS), and on other genes in the MARCKS pathway, as well as on the gene (F52) encoding MARCKS-related protein (Wu et al., 1996) . Although the role of protein kinase C (PKC) in neurulation remains unelucidated, specific inhibition of PKC, the enzyme that phosphorylates MARCKS, has been demonstrated to cause exencephaly in mice (Ward et al., 1998) .
According to the principles of teratology put forth by Wilson (1977) , "Susceptibility to teratogenesis depends on the genotype of the conceptus and the manner in which this interacts with environmental factors." Since the only known genetic difference between the C57BL/6J strain and the C57BL/6J Sp/ϩ mouse is the presence of the splotch allele, it was expected that all malformations that increased in number as a result of introducing the splotch allele via the male would co-segregate with the presence of the allele in the affected fetuses. As with exencephaly and spina bifida aperta, the pres-ence of the malformation, omphalocele, seemed to co-segregate with the splotch allele, although this defect was not observed in sufficient numbers to demonstrate statistical significance. Conversely however, the other malformations and variations noted to increase with the introduction of the splotch allele via the male, namely an/microphthalmia, cardiovascular defects, vertebral fusions, and cervical ribs, did not display co-segregation with the presence of the allele in the fetuses. The increase in cervical ribs may be due to an apparently anomalous decrease of this malformation at day 8.0 in the ϩ/ϩϫϩ/ϩ litters, when compared to days 7.5 and 8.5. It seems possible that the day 8.0 values for this defect are inappropriately low, and thus the apparent increase in splotch litters may be artificial.
A study by Kapron-Bras and Trasler (1984) demonstrated that the introduction of the splotch allele via the male in SWVϫC57BL/6J matings increased the incidence of retinoic acid-induced spina bifida aperta in the progeny. The authors attributed this effect to a delay in closure of the posterior neuropore, which they observed in progeny of the SWV ϫ C57BL/6J Sp/ϩ matings, but they were unable to genotype the fetuses for the presence of the splotch allele. In later years, this group developed a technique for genotyping the fetuses and revisited this subject (Kapron-Bras and Trasler, 1988) . Surprisingly, gross malformations of the posterior neuropore, as well as the induction of early posterior neuropore closure, occurred with the same frequency in the ϩ/ϩ embryos as in the Sp/ϩ embryos. Other malformations observed in this embryo-culture study also showed no co-segregation with the splotch allele. Although this latter study provides some degree of precedence for the lack of co-segregation of some malformations and variations in the present investigation, it remains difficult to imagine how the presence of the paternal splotch allele in the litter could have an effect on wild-type progeny. It bears noting that, although a different teratogen was used, the above-cited results contrast with the present study in that, here, spina bifida aperta secondary to gestational day 8.0 administration of arsenite was found exclusively in fetuses with the splotch allele.
The teratogenic interaction between chemically-induced fetal malformations and genotype may be viewed in a hierarchical fashion. Differences in sensitivity to teratogens have been well documented at the species level, and numerous studies, including this one, have shown differential sensitivity in inbred strains of mice. Differential strain sensitivity in mice may be analogous to documented differences in racial sensitivity to various fetal malformations in humans. The Irish and Sikh populations, for example, are much more sensitive to anencephaly, the human equivalent of exencephaly, than are most other human populations (Leck, 1977) . Extending the hierarchy, it has been observed in this investigation that a mutation in a single gene in the more sensitive strain can increase the effects of a chemical teratogen. This may be analogous to a sensitive subpopulation of humans. The goal of this study has been to determine murine genetic factors that enhance susceptibility to the major malformations induced by arsenic. It would be interesting to determine whether these susceptible genotypes not only have an increased incidence of malformations, but also have a decreased teratogenic threshold. The high doses of arsenite utilized in the present study are only relevant to the human situation if genetic factors can be accumulated that increase sensitivity and/or multiple teratogenic insults can be identified that additively or synergistically cause a particular congenital malformation.
